Semaglutide weight and anthropometric outcomes in obesity over long-term follow-up
Nature Medicine
2024
Study summary
Prespecified analysis of long-term weight and anthropometric outcomes with semaglutide in obesity.
Peptides studied
Goals studied
Stack studied
Metabolic Stack
Key findings
Semaglutide produced sustained weight reduction over extended follow-up in obesity populations.
Study details
Study type
clinical trial analysis
Journal
Nature Medicine
DOI / PubMed
10.1038/s41591-024-02996-7
Year
2024
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.